Back
Verve Therapeutics Vs. Sage Therapeutics Industry Stock Comparison
Sell
1
VERV
Verve Therapeutics
Last Price:
4.85
Seasonality Move:
-11.16%
Sell
27
SAGE
Sage Therapeutics
Last Price:
5.15
Seasonality Move:
13.05%
Sell
1
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy, Sell or Hold?
- The current Verve Therapeutics [VERV] share price is $4.85. The Score for VERV is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- VERV is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy, Sell or Hold?
- The current Sage Therapeutics [SAGE] share price is $5.17. The Score for SAGE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VERV Stock Price Chart
What is Verve Therapeutics's stock price today?
-
The Verve Therapeutics share price today is $4.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.
SAGE Stock Price Chart
What is Sage Therapeutics's stock price today?
-
The Sage Therapeutics share price today is $5.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
VERV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 40.26 | Sell |
Chaikin Money Flow: | 1039980 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.04 - 6.28) | Sell |
Bollinger Bands (100): | (4.83 - 6.53) | Sell |
SAGE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 35.68 | Sell |
Chaikin Money Flow: | 677330 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.14 - 7.48) | Sell |
Bollinger Bands (100): | (6.13 - 10.09) | Sell |
VERV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.91 | Sell |
20-day SMA: | 5.65 | Sell |
50-day SMA: | 5.36 | Sell |
200-day SMA: | 7.32 | Sell |
8-day EMA: | 4.99 | Sell |
20-day EMA: | 5.35 | Sell |
50-day EMA: | 5.47 | Sell |
200-day EMA: | 7.4 | Sell |
SAGE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.1 | Buy |
20-day SMA: | 5.94 | Sell |
50-day SMA: | 6.71 | Sell |
200-day SMA: | 11.95 | Sell |
8-day EMA: | 5.19 | Sell |
20-day EMA: | 5.77 | Sell |
50-day EMA: | 6.69 | Sell |
200-day EMA: | 12.01 | Sell |
Verve Therapeutics Earnings Growth & VERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and a decrease next year of $0.48 per share.
Sage Therapeutics Earnings Growth & SAGE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.06 per share, and an increase next year of $2.71 per share.
Verve Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sage Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |